1. Home
  2. AWRE vs ICCC Comparison

AWRE vs ICCC Comparison

Compare AWRE & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • ICCC
  • Stock Information
  • Founded
  • AWRE 1986
  • ICCC 1982
  • Country
  • AWRE United States
  • ICCC United States
  • Employees
  • AWRE N/A
  • ICCC N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • ICCC Health Care
  • Exchange
  • AWRE Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • AWRE 50.3M
  • ICCC 60.1M
  • IPO Year
  • AWRE 1996
  • ICCC 1987
  • Fundamental
  • Price
  • AWRE $2.74
  • ICCC $6.56
  • Analyst Decision
  • AWRE
  • ICCC
  • Analyst Count
  • AWRE 0
  • ICCC 0
  • Target Price
  • AWRE N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • AWRE 41.3K
  • ICCC 7.5K
  • Earning Date
  • AWRE 10-29-2025
  • ICCC 08-14-2025
  • Dividend Yield
  • AWRE N/A
  • ICCC N/A
  • EPS Growth
  • AWRE N/A
  • ICCC N/A
  • EPS
  • AWRE N/A
  • ICCC 0.20
  • Revenue
  • AWRE $16,146,999.00
  • ICCC $28,274,756.00
  • Revenue This Year
  • AWRE N/A
  • ICCC N/A
  • Revenue Next Year
  • AWRE N/A
  • ICCC N/A
  • P/E Ratio
  • AWRE N/A
  • ICCC $31.55
  • Revenue Growth
  • AWRE N/A
  • ICCC 21.75
  • 52 Week Low
  • AWRE $1.35
  • ICCC $3.34
  • 52 Week High
  • AWRE $2.78
  • ICCC $7.60
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 65.88
  • ICCC 55.18
  • Support Level
  • AWRE $2.20
  • ICCC $6.29
  • Resistance Level
  • AWRE $2.43
  • ICCC $6.80
  • Average True Range (ATR)
  • AWRE 0.19
  • ICCC 0.20
  • MACD
  • AWRE 0.01
  • ICCC 0.05
  • Stochastic Oscillator
  • AWRE 92.75
  • ICCC 59.55

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: